General MedicationsINTRAVENOUSStandard
MEROPENEM
MEROPENEM
Standard Dose
2GM/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MEROPENEM is listed in Drugs@FDA under application 219084 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MEROPENEM Form and strength POWDER;INTRAVENOUS - 2GM/VIAL Sponsor BROOKS STERISCIENCE Submission history Latest submission status date: 2025-06-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview MEROPENEM is listed in Drugs@FDA under application 219084 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MEROPENEM Form and strength POWDER;INTRAVENOUS - 2GM/VIAL Sponsor BROOKS STERISCIENCE Submission history Latest submission status date: 2025-06-23 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.